NCT06828523 Assessing Perceptual Effects of Interactive Tasks
| NCT ID | NCT06828523 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Penn State University |
| Condition | Amyotrophic Lateral Sclerosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,300 participants |
| Start Date | 2025-10-17 |
| Primary Completion | 2029-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,300 participants in total. It began in 2025-10-17 with a primary completion date of 2029-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, we will evaluate how solo, naive listeners perceive the speech of people with amyotrophic lateral sclerosis (ALS) and age-matched speakers produced across interactive and non-interactive contexts with an unfamiliar, naive interlocutor.
Eligibility Criteria
Inclusion Criteria: * passing the remote hearing screening * having no known speech, language or neurological disorders per self-report * being a native monolingual speaker of American English * having no experience communicating with people with dysarthria * being between the ages of 18 and 65. Exclusion Criteria: * None - if volunteer meets the inclusion criteria, then they will be enrolled
Contact & Investigator
Jimin Lee, Ph.D.
PRINCIPAL INVESTIGATOR
The Pennsylvania State University
Frequently Asked Questions
Who can join the NCT06828523 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Amyotrophic Lateral Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06828523 currently recruiting?
Yes, NCT06828523 is actively recruiting participants. Contact the research team at ajo150@psu.edu for enrollment information.
Where is the NCT06828523 trial being conducted?
This trial is being conducted at University Park, United States.
Who is sponsoring the NCT06828523 clinical trial?
NCT06828523 is sponsored by Penn State University. The principal investigator is Jimin Lee, Ph.D. at The Pennsylvania State University. The trial plans to enroll 1,300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.